ImmunityBio, Inc.IBRXNASDAQ
Loading
Year-over-year debt growth rate
5Y CAGR
+59.8%/yr
Long-term compound
Percentile
P87
Within normal range
vs 5Y Ago
10.4x
Strong expansion
Streak
1 qtr
Consecutive growthStable
| Period | Value |
|---|---|
| Q4 2025 | 61.94% |
| Q3 2025 | 1.30% |
| Q2 2025 | 1.72% |
| Q1 2025 | 4.39% |
| Q4 2024 | -32.14% |
| Q3 2024 | 0.99% |
| Q2 2024 | 0.58% |
| Q1 2024 | 0.64% |
| Q4 2023 | 1.32% |
| Q3 2023 | -12.44% |
| Q2 2023 | 6.90% |
| Q1 2023 | 5.87% |
| Q4 2022 | -4.96% |
| Q3 2022 | 6.46% |
| Q2 2022 | 4.42% |
| Q1 2022 | 6.10% |
| Q4 2021 | 87.10% |
| Q3 2021 | 4.01% |
| Q2 2021 | 3.83% |
| Q1 2021 | 15.98% |
| Q4 2020 | 5.95% |
| Q3 2020 | 1971.44% |
| Q2 2020 | -8.46% |
| Q1 2020 | -7.63% |
| Q4 2019 | -6.95% |
| Q3 2019 | 6.40% |
| Q2 2019 | -4.93% |
| Q1 2019 | 128.29% |
| Q4 2018 | -5.38% |
| Q3 2018 | 6.58% |
| Q2 2018 | -2.43% |
| Q1 2018 | -3.37% |
| Q4 2017 | -3.18% |
| Q3 2017 | -66.43% |
| Q2 2017 | 180.20% |
| Q1 2017 | -2.79% |
| Q4 2016 | 6.58% |
| Q3 2016 | 218.70% |
| Q2 2016 | -1.39% |
| Q1 2016 | -0.69% |